Who is eligible for clinical trial NCT06911229?

Participants must meet the protocol's inclusion criteria for Parkinson Disease. The stated age range is 18 Years to 80 Years. Confirm all requirements with the study coordinator.

Does clinical trial NCT06911229 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-07-13

Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease (NCT06911229)

🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: University of Florida

🩺 Plain-English Summary (8th-Grade Level)

Locomotor adaptation will be studied using an established split-belt treadmill paradigm, consisting of baseline (1:1 speed ratio), split-belt adaptation (2:1) and post-adaptation (1:1) walking. Split-belt walking will be performed under DBS ON and DBS OFF conditions, while off-medication.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (5 items) and avoid the listed exclusions (3 items).

Location: University of Florida — Gainesville, Florida

Age range: 18 Years to 80 Years

🧪 Interventions in This Study

Deep Brain Stimulation (DBS) (DEVICE)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

consensus diagnosis of idiopathic PD by fellowship trained movement disorders neurologists at the Normal Fixel Institute of Neurological Diseases;
chronically stable DBS, defined as having had DBS for at least 6 months in duration with optimized DBS settings;
Age between 18 - 80 years old per the FDA data sheet for PD DBS;
no dementia according to the clinical diagnostic criteria for PD dementia;
ambulatory without the use of walking aids, or another person's assistance.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
other previous neurological surgery;
suspicion of other neurologic diagnoses such as atypical parkinsonism, or Alzheimer's disease.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

University of Florida — Gainesville, Florida

📞 Contact the Study Coordinator

Phone: (352) 294-1720

Email: juliachoi@ufl.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Parkinson Disease

Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation — Tucson, Arizona
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations — Little Rock, Arkansas
Investigating Inhibitory Control Networks in Parkinson's Disease — Birmingham, Alabama
Parkinson's Disease Progression Study — Aurora, Colorado
The GBA Multimodal Study in Parkinson's Disease — Portland, Oregon
Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements — East Lansing, Michigan

Explore by condition: All Parkinson Disease clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Contact the study coordinator using the phone/email above.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗